Biofrontera Inc (BFRI) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $0.93
• Market Cap: $10.66M
• EPS: $-1.50
• 52-Week High: $1.19
• 52-Week Low: $0.54

Market Sentiment

Biofrontera Inc currently has a Bullish sentiment score of 0.18.

About Biofrontera Inc

Biofrontera Inc. is a biopharmaceutical company headquartered in Woburn, Massachusetts, specializing in the development and commercialization of innovative dermatological therapies for various skin conditions. By leveraging its proprietary technologies, Biofrontera strives to enhance treatment efficacy and patient outcomes in the U.S. dermatology market. The company is committed to improving dermatological care and is actively expanding its product portfolio to solidify its position as a key ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Biofrontera Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BFRI pay dividends?

Biofrontera Inc (BFRI) does not currently pay a regular dividend.

What is BFRI's market cap?

Biofrontera Inc (BFRI) has a market capitalization of $10.66M with a current stock price of $0.93.